MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Perrigo Co PLC

Închisă

SectorSănătate

27.9 0.87

Rezumat

Modificarea prețului

24h

Curent

Minim

27.39

Maxim

27.93

Indicatori cheie

By Trading Economics

Venit

-24M

-45M

Vânzări

51M

1.1B

P/E

Medie Sector

2,570

63.778

EPS

0.93

Randament dividend

4.14

Marjă de profit

-3.909

Angajați

8,379

EBITDA

35M

114M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+20.32% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

4.14%

2.39%

Următoarele câștiguri

6 mai 2025

Data viitoare de dividende

17 iun. 2025

Următoarea dată ex-dividende

29 mai 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

459M

3.8B

Deschiderea anterioară

27.03

Închiderea anterioară

27.9

Sentimentul știrilor

By Acuity

35%

65%

122 / 386 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

Perrigo Co PLC Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

28 feb. 2025, 17:42 UTC

Principalele dinamici ale pieței

Perrigo Shares Jump on FDA's Move to Reclassify Wisconsin Infant-Formula Plant

27 feb. 2025, 23:52 UTC

Câștiguri

Perrigo Gets Facility Reclassification From FDA as 4Q Profit, Revenue Fall

Comparație

Modificare preț

Perrigo Co PLC Așteptări

Obiectiv de preț

By TipRanks

20.32% sus

Prognoză pe 12 luni

Medie 33.33 USD  20.32%

Maxim 42 USD

Minim 27 USD

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPerrigo Co PLC - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

4 ratings

1

Cumpărare

3

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

27.36 / 27.81Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Bullish Evidence

Termen lung

Strong Bullish Evidence

Sentiment

By Acuity

122 / 386 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Perrigo Co PLC

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.